Immunogenicity and safety of a SARS-CoV-2 N-terminal domain and receptor-binding domain monovalent XBB.1.5 vaccine in Japanese participants.
- DOI
- 10.1016/j.vaccine.2025.127960
- Published
- 2026 Jan 1
- Container
- Vaccine
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.vaccine.2025.127960,
title = {Immunogenicity and safety of a SARS-CoV-2 N-terminal domain and receptor-binding domain monovalent XBB.1.5 vaccine in Japanese participants.},
author = {Grassi CM and Feng J and Wahid R and Kandinov B and Goel S and Wang D and Sellers K and Dixit A and Kogawara O and Das R and Chalkias S},
year = {2026},
journal = {Vaccine},
doi = {10.1016/j.vaccine.2025.127960},
url = {https://doi.org/10.1016/j.vaccine.2025.127960}
}RIS
TY - JOUR TI - Immunogenicity and safety of a SARS-CoV-2 N-terminal domain and receptor-binding domain monovalent XBB.1.5 vaccine in Japanese participants. AU - Grassi CM AU - Feng J AU - Wahid R AU - Kandinov B AU - Goel S AU - Wang D AU - Sellers K AU - Dixit A AU - Kogawara O AU - Das R AU - Chalkias S PY - 2026 JO - Vaccine DO - 10.1016/j.vaccine.2025.127960 UR - https://doi.org/10.1016/j.vaccine.2025.127960 ER -
APA
CM, G., J, F., R, W., B, K., S, G., D, W., K, S., A, D., O, K., R, D., & S, C. (2026). Immunogenicity and safety of a SARS-CoV-2 N-terminal domain and receptor-binding domain monovalent XBB.1.5 vaccine in Japanese participants.. Vaccine. https://doi.org/10.1016/j.vaccine.2025.127960
Source records
- pubmed · retrieved 2026-09-26T01:32:59.555Z
- europe-pmc · retrieved 2026-09-26T01:32:59.566Z